Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IDEXX Laboratories Inc (NASDAQ:IDXX)

93.76
BATS BZX Real-Time Price
As of 12:29pm ET
 +0.69 / +0.74%
Today’s Change
63.48
Today|||52-Week Range
95.55
+28.58%
Year-to-Date
Baron Funds Comments on IDEXX Laboratories Inc.
Jul 25 / GuruFocus News - Paid Partner Content
Trade-Ideas: IDEXX Laboratories (IDXX) Is Today's Strong And Under The Radar Stock
Jul 20 / TheStreet.com - Paid Partner Content
Baron Asset Fund 2nd Quarter Letter
Jul 25 / GuruFocus News - Paid Partner Content
Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive
Jul 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close93.07
Today’s open93.17
Day’s range93.12 - 93.82
Volume9,362
Average volume (3 months)725,496
Market cap$8.3B
Dividend yield--
Data as of 12:29pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+14.53%
Earnings growth (this year)+4.74%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.81%
P/E ratio45.2
Price/Sales4.26
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.33-0.94%
VRXValeant Pharmaceutic...-0.07-0.31%
RDYDr.Reddy's Laborator...-8.16-15.66%
ALKSAlkermes Plc+1.17+2.33%
Data as of 12:32pm ET, 07/26/2016

Financials

Last reporting dateJuly 22, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$1.6B
Annual profit (last year)$192.1M
Net profit margin11.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts

Partner Offers

Search for Jobs